Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Woodham AW, Cheloha RW, Ling J, Rashidian M, Kolifrath SC, Mesyngier M, Duarte JN, Bader JM, Skeate JG, Da Silva DM, Kast WM, Ploegh HL.

Cancer Immunol Res. 2018 Jul;6(7):870-880. doi: 10.1158/2326-6066.CIR-17-0661. Epub 2018 May 23.

PMID:
29792298
2.

An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model.

Chahal JS, Fang T, Woodham AW, Khan OF, Ling J, Anderson DG, Ploegh HL.

Sci Rep. 2017 Mar 21;7(1):252. doi: 10.1038/s41598-017-00193-w.

3.

Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro.

Woodham AW, Sanna AM, Taylor JR, Skeate JG, Da Silva DM, Dekker LV, Kast WM.

Virol J. 2016 Nov 18;13(1):187.

4.

Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

Pulido MA, DerHartunian MK, Qin Z, Chung EM, Kang DS, Woodham AW, Tsou JA, Klooster R, Akbari O, Wang L, Kast WM, Liu SV, Verschuuren JJGM, Aswad DW, Laird-Offringa IA.

J Neuroimmunol. 2016 Oct 15;299:70-78. doi: 10.1016/j.jneuroim.2016.09.002. Epub 2016 Sep 3.

5.

Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Woodham AW, Skeate JG, Sanna AM, Taylor JR, Da Silva DM, Cannon PM, Kast WM.

AIDS Patient Care STDS. 2016 Jul;30(7):291-306. doi: 10.1089/apc.2016.0100. Review.

6.

T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.

Woodham AW, Yan L, Skeate JG, van der Veen D, Brand HH, Wong MK, Da Silva DM, Kast WM.

Papillomavirus Res. 2016 Dec;2:21-30.

7.

Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.

Nicol AF, Brunette LL, Nuovo GJ, Grinsztejn B, Friedman RK, Veloso VG, Cunha CB, Coutinho JR, Vianna-Andrade C, Oliveira NS, Woodham AW, DA Silva DM, Kast WM.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):27-33. doi: 10.1097/QAI.0000000000001049. Erratum in: J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):e66.

8.

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

Skeate JG, Woodham AW, Einstein MH, Da Silva DM, Kast WM.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1418-29. doi: 10.1080/21645515.2015.1136039. Epub 2016 Feb 2. Review.

9.

Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.

Da Silva DM, Woodham AW, Rijkee LK, Skeate JG, Taylor JR, Koopman ME, Brand HE, Wong MK, McKee GM, Salazar AM, Kast WM.

Papillomavirus Res. 2015 Dec 1;1:12-21. doi: 10.1016/j.pvr.2015.05.001.

10.

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.

Da Silva DM, Woodham AW, Naylor PH, Egan JE, Berinstein NL, Kast WM.

J Interferon Cytokine Res. 2016 May;36(5):291-301. doi: 10.1089/jir.2015.0115. Epub 2015 Dec 10.

11.

Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.

Skeate JG, Porras TB, Woodham AW, Jang JK, Taylor JR, Brand HE, Kelly TJ, Jung JU, Da Silva DM, Yuan W, Kast WM.

J Gen Virol. 2016 Feb;97(2):422-34. doi: 10.1099/jgv.0.000341. Epub 2015 Nov 10.

12.

Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman LD, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM.

Clin Immunol. 2015 Dec;161(2):197-208. doi: 10.1016/j.clim.2015.09.003. Epub 2015 Sep 8.

13.

A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours.

Bogaert L, Woodham AW, Da Silva DM, Martens A, Meyer E, Kast WM.

J Gen Virol. 2015 Sep;96(9):2764-8. doi: 10.1099/vir.0.000212. Epub 2015 Jun 4.

14.

Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection.

Woodham AW, Taylor JR, Jimenez AI, Skeate JG, Schmidt T, Brand HE, Da Silva DM, Kast WM.

J Antimicrob Chemother. 2015;70(6):1686-90. doi: 10.1093/jac/dkv045. Epub 2015 Feb 23.

15.

Functional analysis of HPV-like particle-activated Langerhans cells in vitro.

Yan L, Woodham AW, Da Silva DM, Kast WM.

Methods Mol Biol. 2015;1249:333-50. doi: 10.1007/978-1-4939-2013-6_25.

16.

Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.

Woodham AW, Raff AB, Da Silva DM, Kast WM.

Methods Mol Biol. 2015;1249:135-49. doi: 10.1007/978-1-4939-2013-6_10.

17.

Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.

Woodham AW, Raff AB, Raff LM, Da Silva DM, Yan L, Skeate JG, Wong MK, Lin YG, Kast WM.

J Immunol. 2014 May 15;192(10):4748-57. doi: 10.4049/jimmunol.1303190. Epub 2014 Apr 9.

18.

The evolving field of human papillomavirus receptor research: a review of binding and entry.

Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, Schelhaas M, Kast WM.

J Virol. 2013 Jun;87(11):6062-72. doi: 10.1128/JVI.00330-13. Epub 2013 Mar 27. Review.

19.

The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.

Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, Isas JM, Langen R, Kast WM.

PLoS One. 2012;7(8):e43519. doi: 10.1371/journal.pone.0043519. Epub 2012 Aug 22.

20.

The role of the lumbar multifidus in chronic low back pain: a review.

Freeman MD, Woodham MA, Woodham AW.

PM R. 2010 Feb;2(2):142-6; quiz 1 p following 167. doi: 10.1016/j.pmrj.2009.11.006. Review.

PMID:
20193941

Supplemental Content

Loading ...
Support Center